Oxygen therapy study on heart nerves ends early
NCT ID NCT07537452
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how breathing pure oxygen in a high-pressure chamber (hyperbaric oxygen therapy) changes the body's automatic heart control in people with neurological injury. Researchers planned to measure heart rate variability in 17 patients before and after treatment. The study was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 100% oxygen in a hyperbaric chamber
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGICAL INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
hyperbaric center Asaf harofe medical center
Rishon LeZiyyon, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.